4//SEC Filing
Shacham Sharon 4
Accession 0001209191-22-011639
CIK 0001503802other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:15 PM ET
Size
7.6 KB
Accession
0001209191-22-011639
Insider Transaction Report
Form 4
Shacham Sharon
CSO & Pres. Res. & Dev.
Transactions
- Sale
Common Stock
2022-02-17$12.12/sh−9,088$110,177→ 904,357 total - Sale
Common Stock
2022-02-17$12.12/sh−9,079$110,068→ 698,983 total(indirect: By Spouse)
Footnotes (4)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees.
- [F3]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the spouse of the reporting person.
- [F4]The sale price of the spouse of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001588438
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:15 PM ET
- Size
- 7.6 KB